SynRx Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

SynRx General Information

Description

Developer of a novel therapeutic approach intended for targeted drug delivery. The company's platform utilizes living microorganisms loaded with therapeutic drugs, designed for precise delivery to tumor sites, and recognizes tumor characteristics, enabling healthcare businesses to achieve maximized therapeutic effects due to the delivery capabilities of living medicine.

Contact Information

Website
www.synrx.co.kr
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Seoul
  • South Korea
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Corporate Office
  • Seoul
  • South Korea

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SynRx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 03-Feb-2025 Completed Out of Business
3. Accelerator/Incubator 01-May-2023 Completed Startup
2. Seed Round Completed Startup
1. Accelerator/Incubator Completed Startup
To view SynRx’s complete valuation and funding history, request access »

SynRx FAQs

  • When was SynRx founded?

    SynRx was founded in 2022.

  • Where is SynRx headquartered?

    SynRx is headquartered in Seoul, South Korea.

  • What industry is SynRx in?

    SynRx’s primary industry is Drug Discovery.

  • Is SynRx a private or public company?

    SynRx is a Private company.

  • What is SynRx’s current revenue?

    The current revenue for SynRx is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process